Related references
Note: Only part of the references are listed.Important role for AMPKα1 in limiting skeletal muscle cell hypertrophy
Remi Mounier et al.
FASEB JOURNAL (2009)
Skeletal Muscle AMP-activated Protein Kinase Is Essential for the Metabolic Response to Exercise in Vivo
Robert S. Lee-Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
C. Florian Bentzinger et al.
CELL METABOLISM (2008)
Does AMP-activated protein kinase negatively 7 mediate aged fast-twitch skeletal muscle mass
Scott E. Gordon et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2008)
AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice
Ping Zhang et al.
HYPERTENSION (2008)
AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions
David M. Thomson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
Anita Y. M. Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase α1 following overload in LKB1 knockout mice
Sean L. Mcgee et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
AMPK and raptor: Matching cell growth to energy supply
D. Grahame Hardie
MOLECULAR CELL (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes
Kazuki Nakashima et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2007)
S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase
Victor Aguilar et al.
CELL METABOLISM (2007)
Role of the α2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia
Elham Zarrinpashneh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle
Hans C. Dreyer et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Skeletal muscle hypertrophy and atrophy signaling pathways
DJ Glass
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control
M Ohanna et al.
NATURE CELL BIOLOGY (2005)
Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation
DM Thomson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status
SWY Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside- but not contraction-induced glucose uptake in skeletal muscle
SB Jorgensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte
AYM Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway
N Kimura et al.
GENES TO CELLS (2003)
AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation
HH Zong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis
S Horman et al.
CURRENT BIOLOGY (2002)
Control of p70 ribosornal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes
U Krause et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification
G Pallafacchina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
DR Bolster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
